Amalgamated Financial’s Organon & Co OGN Stock Holding History

Amalgamated Financial’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$2.91M	Buy	+83,432	New	+$2.85M	0.02%	745

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Amalgamated Financial's OGN Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Organon & Co (OGN) in Q1 2022: 83,432 shares worth $2.91M. The stake represents 0.02% of the portfolio and ranks #745 among its holdings.

819 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

Amalgamated Financial held 83,432 shares of Organon & Co worth $2.91M as of Q1 2022.
Organon & Co was a new Amalgamated Financial position in Q1 2022.
Organon & Co made up 0.02% of Amalgamated Financial's portfolio in Q1 2022, its #745 holding.
819 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.